Stephen V Liu, Director of Thoracic Oncology, Chief, Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X about a paper by Robert C. Grant et al. published in JAMA Oncology:
“Development of chronic kidney disease after cisplatin chemotherapy use in JAMA Oncology. In over 9000 patients, 13.6% of patients developed CKD. Estimated glomerular filtration rate decreased by a mean of 8.1 mL/min/1.73m2, and low baseline eGFR was the greatest predictor of CKD.”
Title: Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data
Authors: Robert C. Grant, Jiang Chen He, Ning Liu, Sho Podolsky, Faiyaz Notta, Marzyeh Ghassemi, Steven Gallinger, Andrea Knezevic, Sheron Latcha, Edgar Jaimes, Abhijat Kitchlu, Kelvin Chan
You can read the Full Article on JAMA Oncology.
More posts featuring Stephen V Liu.